Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unity Biotechnology Inc (UBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8165
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The company’s product portfolio includes UBX0101, intended for musculoskeletal diseases; and UBX1967, for ophthalmologic diseases, including diabetic retinopathy and diabetic macular edema, glaucoma and age-related macular degeneration. Unity Biotechnology is also developing products for idiopathic pulmonary fibrosis, systemic sclerosis, chronic obstructive pulmonary disease, cognition and kidney disease. The company works in collaboration with research institutions, academic, contract research organizations to develop its product portfolio. Unity Biotechnology is headquartered in Brisbane, California, the US.

Unity Biotechnology Inc (UBX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unity Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Unity Biotech Raises USD55 Million in Series C Financing 11
Unity Biotech Raises Additional USD35 Million in Series B Financing 13
UNITY Biotech Raises USD116 Million in Series B Financing 15
Unity Biotechnology Raises Funds in Venture Financing 17
Partnerships 18
Ascentage Pharma Enters Agreement with Unity Biotechnology 18
Equity Offering 19
Unity Biotech Raises USD85 Million in IPO of Shares 19
Debt Offering 20
Unity Biotechnology Raises USD4 Million in Public Offering of 5% Notes Due 2017 20
Unity Biotechnology Inc – Key Competitors 21
Unity Biotechnology Inc – Key Employees 22
Unity Biotechnology Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Aug 09, 2018: Unity Biotechnology announces second quarter 2018 financial results 24
Jun 07, 2018: UNITY Biotechnology Reports First Quarter 2018 Financial Results 25
Corporate Communications 26
Jun 13, 2018: UNITY Biotechnology added to Russell 3000, 2000 and MicroCap Indexes 26
May 14, 2018: UNITY Biotechnology names Camille Landis as senior vice president of corporate development 27
Mar 27, 2018: UNITY Biotechnology Appoints Pharmaceutical Industry Executive Paul L. Berns to Board of Directors 28
Feb 07, 2018: UNITY Biotechnology Adds David L. Lacey As Board Director 29
Sep 21, 2017: UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team 30
Product News 31
Jul 09, 2018: First patient treated with drug based on Buck research 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unity Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unity Biotechnology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unity Biotech Raises USD55 Million in Series C Financing 11
Unity Biotech Raises Additional USD35 Million in Series B Financing 13
UNITY Biotech Raises USD116 Million in Series B Financing 15
Unity Biotechnology Raises Funds in Venture Financing 17
Ascentage Pharma Enters Agreement with Unity Biotechnology 18
Unity Biotech Raises USD85 Million in IPO of Shares 19
Unity Biotechnology Raises USD4 Million in Public Offering of 5% Notes Due 2017 20
Unity Biotechnology Inc, Key Competitors 21
Unity Biotechnology Inc, Key Employees 22

List of Figures
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mediaset S.p.A.:企業の戦略・SWOT・財務分析
    Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hotels.com LP:企業の戦略・SWOT・財務情報
    Hotels.com LP - Strategy, SWOT and Corporate Finance Report Summary Hotels.com LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Stolt-Nielsen Ltd (SNI):石油・ガス:M&Aディール及び事業提携情報
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company operates a fleet of deep-sea, regional, coastal and inland parcel tankers, to offers transportation services to the manu …
  • Industrial and Commercial Bank of China Ltd:企業のM&A・事業提携・投資動向
    Industrial and Commercial Bank of China Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Industrial and Commercial Bank of China Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Bet Shemesh Engines Holdings (1997) Ltd
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Giesecke & Devrient GmbH:企業の戦略・SWOT・財務分析
    Giesecke & Devrient GmbH - Strategy, SWOT and Corporate Finance Report Summary Giesecke & Devrient GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kansas City Deaerator Co:企業の戦略的SWOT分析
    Kansas City Deaerator Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Skanska AB:企業の戦略・SWOT・財務分析
    Skanska AB - Strategy, SWOT and Corporate Finance Report Summary Skanska AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pinnacle West Capital Corporation:企業の戦略・SWOT・財務分析
    Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cellnovo Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management systems such as insulin patch pump, cellular-enabled wireless touchscreen handset with integrated blood glucose meter, acti …
  • Mechel:企業のM&A・事業提携・投資動向
    Mechel - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mechel Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • The Dun & Bradstreet Corporation:企業の戦略・SWOT・財務分析
    The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report Summary The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Omega Diagnostics Group Plc (ODX):企業の製品パイプライン分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company offers products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests fo …
  • Sunnova Energy Corporation:電力:M&Aディール及び事業提携情報
    Summary Sunnova Energy Corporation (Sunnova Energy) is engaged in providing solar power services to homeowners. The company is involved in installing and generating power. It offers solar service agreements such as EZ Pay PPA, PPA, EZ own plan, and solar lease plan. In addition, the company offers s …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Shin-Etsu Chemical Co Ltd (4063):企業の財務・戦略的SWOT分析
    Shin-Etsu Chemical Co Ltd (4063) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆